Article Type
Article
Changed
Fri, 02/01/2019 - 08:06
Display Headline
COX-2 inhibitors: Balancing the hope, the hype, and the concern
Author(s)
Brian F. Mandell, MD, PhD
Article PDF
content_68_899.pdf
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Issue
Cleveland Clinic Journal of Medicine - 68(11)
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Vascular
Preventive Care
Drug Therapy
Page Number
899
Sections
From the Editor
Author(s)
Brian F. Mandell, MD, PhD
Author(s)
Brian F. Mandell, MD, PhD
Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Author and Disclosure Information

Brian F. Mandell, MD, PhD
Deputy Editor

Article PDF
content_68_899.pdf
Article PDF
content_68_899.pdf
Related Articles
COX-2 inhibitors and cardiovascular risk: Point and counterpoint
COX-2 inhibitors and cardiovascular risk: The data are inconclusive, and these drugs are needed
COX-2 inhibitors and cardiovascular risk: We defend our data and suggest caution
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Issue
Cleveland Clinic Journal of Medicine - 68(11)
Page Number
899
Page Number
899
Publications
Cleveland Clinic Journal of Medicine
Publications
Cleveland Clinic Journal of Medicine
Topics
Cardiology
Vascular
Preventive Care
Drug Therapy
Article Type
Article
Display Headline
COX-2 inhibitors: Balancing the hope, the hype, and the concern
Display Headline
COX-2 inhibitors: Balancing the hope, the hype, and the concern
Sections
From the Editor
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media